EDGAR Filing Documents for 0001801170-23-000021

Form 8-K - Current report:

SEC Accession No. 0001801170-23-000021

Filing Date

2023-04-20

Accepted

2023-04-20 16:06:10

Documents

Period of Report

2023-04-16

Items

Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	clov-20230416.htm iXBRL	8-K	44983
2	EX-99.1	exhibit991-alphapressrelea.htm	EX-99.1	12608
6	LOGO	image.jpg	GRAPHIC	14723
	Complete submission text file	0001801170-23-000021.txt		225757

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	clov-20230416.xsd	EX-101.SCH	1902
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	clov-20230416_lab.xml	EX-101.LAB	24849
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	clov-20230416_pre.xml	EX-101.PRE	13046
8	EXTRACTED XBRL INSTANCE DOCUMENT	clov-20230416_htm.xml	XML	11690

Mailing Address 3401 MALLORY LANE, SUITE 210 FRANKLIN TN 37067

Business Address 3401 MALLORY LANE, SUITE 210 FRANKLIN TN 37067 (201) 432-2133

CLOVER HEALTH INVESTMENTS, CORP. /DE (Filer) CIK: 0001801170 (see all company filings)